AMFR and metabolic dysfunction-associated steatohepatitis: However it allows for the possibility that hepatocytes with the same gp78 null genetic background are differentially at risk of steatosis and gp78 deletion by itself is insufficient for NASH progress, which is simultaneously induced by age-dependent ‘second hit’.